Transcell Oncologics

Transcell Oncologics leverages unique insights from adult stem cells obtained from patients, donor samples, and predictive stem cell technologies to discover anti-cancer stem cell properties and identify drugable molecules that can selectively kill cancer. We are committed to supporting innovative in vitro science and applications by reducing and replacing animal testing through the products we provide to the global market. Our expertise lies in the production, characterization, supply, and specialized in vitro testing services of platforms based on primary, progenitor cells/tissues, guiding users through preclinical exploratory research needs across the pharmaceutical, vaccine, and cosmetics industries. We believe that the right type of testing platform, along with its composition and configuration, determines the fate of the tested materials and their practical applications and functions. Our mission is to provide the best, time-tested in vitro solutions for research needs.